Terrein inhibits keratinocyte proliferation via ERK inactivation and G2/M cell cycle arrest

Dong-Seok Kim1, Hyun-Kyung Lee, Seo-Hyoung Park

  • 1Department of Biochemistry, College of Medicine, Chung-Ang University, Republic of Korea.

Experimental Dermatology
|November 6, 2007
PubMed

Insights

The fungal metabolite terrein inhibits human keratinocyte proliferation by inactivating the extracellular signal-regulated kinase (ERK) pathway. This leads to cell cycle arrest and reduced DNA synthesis, revealing a novel mechanism for terrein

Area of Science:

  • Molecular Biology
  • Dermatology
  • Mycology

Background:

  • Terrene, a fungal metabolite, exhibits significant antiproliferative activity on skin equivalents.
  • Understanding the molecular mechanisms behind terrein's effects on human epidermal keratinocytes is crucial.

Purpose of the Study:

  • To investigate the signaling pathways, specifically extracellular signal-regulated protein kinase (ERK) and Akt, affected by terrein in human epidermal keratinocytes.
  • To elucidate the role of these pathways in terrein-induced growth inhibition.

Main Methods:

  • Treatment of human epidermal keratinocytes with terrein.
  • Analysis of ERK and Akt pathway activation using Western blotting.
  • Cell cycle analysis via flow cytometry.
  • Examination of cell cycle-related protein expression (cyclin B1, Cdc2, p27).

Main Results:

  • Terrene inactivated the ERK pathway, leading to keratinocyte proliferation inhibition; the Akt pathway remained unaffected.
  • Terrene treatment resulted in reduced DNA synthesis, with cells accumulating in the G2/M phase of the cell cycle.
  • Terrene downregulated cyclin B1 and Cdc2 expression while upregulating p27(KIP1), a cyclin-dependent kinase inhibitor.

Conclusions:

  • Extracellular signal-regulated kinase (ERK) pathway inhibition is a key mechanism by which terrein reduces human keratinocyte proliferation.
  • Terrene induces cell cycle arrest at the G2/M phase by modulating the expression of key cell cycle regulators.
  • These findings highlight terrein's potential as an antiproliferative agent targeting keratinocyte growth.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Renewal of Skin Epidermal Stem Cells01:12

Renewal of Skin Epidermal Stem Cells

The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular cells,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...